[Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
A two-month treatment of the chronic active hepatitis (HBsAg+) with isoprinosine produced quantitative and functional T-cells populations in patients with cellular response disorders. Immunological studies have shown that such an effect of isoprinosine lasted for about 4-5 months. Repeated administration of isoprinosine for one month normalized recurrent abnormalities in the monitored immunological parameters.
Dabrowska-Bernstein
B
B
Zakładu Immunopatologii Instytutu Chorób Zakaźnych i Pasozytniczych, Warszawie.
Stasiak
A
A
Dabrowski
M
M
Pawińska
A
A
Cianciara
J
J
Loch
T
T
Babiuch
L
L
D000276:Adjuvants, Immunologic; D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000009:adverse effects / Q000276:immunology; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use*; D008231:Lymphopenia / Q000150:complications / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D000276:Adjuvants, Immunologic; D006514:Hepatitis B Surface Antigens; D007542:Inosine Pranobex
Ocena leczenia przewlekłego aktywnego zapalenia watroby (HBsAg+) izoprynozyna. II. Badania immunologiczne.